| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0003 | 1 |